Educational sessions in pharmacovigilance: What do the doctors think?
<p>Abstract</p> <p>Background</p> <p>The aim of this study was to determine physicians' opinion regarding pharmacovigilance feedback sessions. A survey was conducted in a teaching hospital, and the physicians who attended the sessions were invited to participate by...
Main Authors: | Arnau Josep, Aguilera Cristina, Danés Immaculada, Cereza Gloria, Agustí Antonia, Pedrós Consuelo, Vallano Antonio |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-11-01
|
Series: | BMC Research Notes |
Online Access: | http://www.biomedcentral.com/1756-0500/3/311 |
Similar Items
-
Unknown adverse drug reactions from spontaneous reports in a hospital setting: characterization, follow-up, and contribution to the pharmacovigilance system
by: Francesca Filippi-Arriaga, et al.
Published: (2023-07-01) -
Adverse Reactions to Drugs of Special Interest in a Pediatric Oncohematology Service
by: Kristopher Amaro-Hosey, et al.
Published: (2021-05-01) -
Revisión sistemática de los estudios de evaluación del coste de las reacciones adversas a medicamentos Systematic review of studies assessing the cost of adverse drug reactions
by: Antonio Vallano Ferraz, et al.
Published: (2012-06-01) -
Clinical pharmacology facing the real-world setting: Pharmacovigilance, pharmacoepidemiology and the economic evaluation of drugs
by: Antonia Agustí, et al.
Published: (2023-11-01) -
Off-label use of rituximab in patients with systemic lupus erythematosus with extrarenal disease activity: a retrospective study and literature review
by: Carla Sans-Pola, et al.
Published: (2023-05-01)